Furthermore, a locus in CDKN2A (9p21.3) that did not reach genome-wide significance in one of the original genome-wide studies [2] was found to be significantly associated with the risk of childhood ALL using a larger European White validation set [9]. Here, CDKN2A is linked to acute lymphoblastic leukemia.